IMPROVEMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PROGRAMS

Recombinant human serum albumin (OsrHSA) has emerged as a substantial innovation in the sphere of biopharmaceuticals, offering promising improvements across various healthcare and industrial programs. With its structural similarity to By natural means derived human serum albumin, OsrHSA presents a safer, additional responsible alternative for thera